The degree to which the association of e4 with dementia is mediated by AD lesions in comparison with vascular lesions is controversial. The present study was undertaken to determine the roles of Alzheimer disease (AD) and vascular pathology in mediating the effect of apolipoprotein E (APOE)-e4 alleles on dementia. Clinicopathologic correlations were studied in 267 Catholic sisters participating in the Nun Study. The extent to which AD and vascular pathologies mediated the effect of APOE-e4 on dementia was investigated using multiple logistic regression. Adjusted for age at death and education, possession of 1 or more e4 alleles was an important risk factor for dementia (odds ratio = 2.98; 95% confidence interval, 1.62-5.48). This association was lost (odds ratio = 1.38; 95% confidence interval, 0.68-2.80) when an index of the severity of AD-related neuropathology was added to the model, but changed little when measures of the severity of vascular pathology were added. The findings suggest that the effect of e4 on dementia is mediated by the severity of AD pathology. Although infarcts and atherosclerosis contribute to the occurrence of dementia, this contribution seems unrelated to APOE genotype.
A t autopsy, demented patients show considerable overlap in pathologic lesions in the brain, with Alzheimer disease (AD) and vascular lesions commonly found. 1, 2 The heterogeneity of pathology raises the question of how these different lesions might mediate the effects of the e4 allele of apolipoprotein E (APOE), an important risk factor for dementia 3 and AD. [3] [4] [5] [6] [7] [8] In the Religious Orders Study (ROS), when the effect of AD pathology was controlled in regression analyses, the association of the e4 allele with clinical AD was reduced by 50%. 9 This finding suggests that much of the effect of this allele on AD was through an association with the classic neuropathologic lesions of this illness. The ROS compared participants with probable AD to controls and excluded persons with other types of dementia, in whom e4 may also have influenced non-AD pathology. In the present study, all cases of dementia were included.
The degree to which the association of e4 with dementia is mediated by vascular lesions in comparison with AD lesions is unknown. The possibility that vascular lesions may play a role in mediating the effects of the e4 allele is raised by studies showing associations between APOE-e4 and increased risk of vascular dementia. [10] [11] [12] [13] and also by a recent study in which APOE-e4 was shown to more than double the odds of cortical and subcortical infarction. 14 We used data from 267 participants in the Nun Study who came to autopsy to examine the roles of AD and vascular pathology in mediating the effect of APOE-e4 alleles. Participants were included regardless of the presence or cause of dementia. Our analyses closely parallel those from the previous ROS publication 9 in determining the effect of adding measures of pathology on the association between the e4 allele and dementia in regression models.
METHODS

Participants
Participants in the Nun Study 15, 16 are members of the School Sisters of Notre Dame congregation and live in communities in the Midwestern, Eastern, and Southern United States. In 1991 and 1992, 678 Catholic sisters, aged 75 to 102 were enrolled who agreed to annual evaluation and brain donation after death. Participants included individuals who were initially demented and those free of dementia and other cognitive impairments. Cognitive and physical function was assessed annually. All participants or their guardians gave informed consent to their participation in this study. Ninety-two percent of those enrolled continued participation and 96% of those who died were autopsied. The present study is based on the first 412 participants who were autopsied. Data on both APOE genotype and ratings of amyloid angiopathy were available for 267 of these participants, who constituted the sample for the present analyses.
Assessment During Life
Cognitive function was evaluated annually with the Consortium to Establish a Registry for Alzheimer Disease (CERAD) neuropsychologic battery. 17 This battery assesses memory, concentration, language, visuospatial ability, and orientation to time and place. Performance-based testing was used to evaluate basic and instrumental activities of daily living. 18, 19 Participants were considered to be demented when all of the following conditions were met: (1) impairment in memory (defined by a score <4 on the Delayed Word Recall Test); (2) impairment in 1 or more other areas of cognition (defined by scores of <11 on Verbal Fluency, <13 on Boston Naming, or <8 on Constructional Praxis); (3) impairment in basic or instrumental activities of daily living (defined by inability to use a telephone, handle money, or dress oneself); and (4) evidence of a decline in ability from a previous level attributable to cognitive impairment. Cut scores selected to define cognitive impairment on tests were based on scores less than the fifth percentile for normal controls in CERAD. 20 
APOE Genotyping
APOE genotyping was performed using genetic material from buccal cells collected from living participants or from frozen or paraffin-embedded brain specimens using laboratory methods described previously. 21 
Neuropathologic Evaluation
Gross and microscopic evaluations of the brains of participants who died during the follow-up period of the study were performed by a board-certified clinical neuropathologist (W.R.M.) who was blinded to diagnosis, cognitive test scores, and functional assessments. Diffuse and neuritic plaques (NPs) and neurofibrillary tangles (NFTs) were counted in the 5 most severely affected fields of the middle frontal gyrus (Brodmann area 9), inferior parietal lobule (areas 39/40), middle temporal gyrus (area 21), and the CA1 and subiculum of the hippocampus after staining with the modified Bielschowsky method. The Gallyas stain, which is better for detecting neuropil threads and argyrophilic grains and slightly better for detecting NFT in medial temporal lobe structures, was used to count the neurofibrillary pathology in CA1 and subiculum of the hippocampus. All sections were cut at 8-mm thickness.
To meet the study's neuropathologic criteria for AD, participants were required to have: (1) abundant senile plaques in the frontal, temporal, or parietal lobes, that is, 16 or more senile plaques per mm 2 ; (2) NPs in at least 1 lobe; and (3) NFT in at least 1 lobe and abundant NFT in the entorhinal cortex, hippocampus, and amygdala. Participants meeting the study's neuropathologic criteria all satisfied CERAD criteria for neuropathologic AD and had a high or intermediate likelihood of neuropathologic AD according to the National Institute on Aging/Reagan Institute guidelines.
Cortical and subcortical infarcts were identified at the gross examination of the intact brain and of 1.5 cm thick coronal sections of the cerebral hemispheres, brainstem, and cerebellum. They were categorized as large (Z1.5 cm) or lacunar (<1.5 cm). The degree of atherosclerosis in the circle of Willis was rated in 4 grades from absent to severe. Because there is no universally accepted staging of atherosclerosis in the circle of Willis, the scale used reflects the subjective impression of the study neuropathologist (W.R.M.) regarding the overall average of involvement of the number of the affected vessels at the base of the brain and the degree of atherosclerotic depositions in these vessels. In the present study, 13% of participants had absent to mild atherosclerosis (plaques present in 0% to less than 25% of the vessel walls of the circle of Willis), 33% moderate (25% to 50% inclusive) and 54% severe (>50%).
Chronic microinfarcts were identified from slides of the caudate nucleus, putamen, globus pallidus, thalamus, internal capsule, frontal lobe (area 9), temporal lobe, parietal lobe, occipital lobe (areas 18 and 19), and hippocampus.
The severity of amyloid angiopathy was rated from 1 (absent) to 4 (severe). The number of blood vessels containing b-amyloid by immunostaining was counted in 6 regions, including the leptomeninges and the cortex of the frontal, parietal, temporal, and occipital lobes and hippocampus. When 6 or more blood vessels contained amyloid in greater than 50% of the wall in 3 or more brain regions and leptomeninges, it was considered as severe. When 2 or more regions and leptomeninges had 6 or more affected vessels it was considered as moderate, and when 1 region showed 6 or more affected vessels it was considered as mild. If the severity was less than this, amyloid angiopathy was considered to be absent. Amyloid angiopathy determined in this manner was absent in 24%, mild in 43%, moderate in 5%, and severe in 28%.
Statistical Methods
Differences between participants with and without 1 or more e4 alleles for individual descriptive variables were assessed with Wilcoxon rank-sum and w 2 tests. An exploratory principal components analysis partialing out the effects of age at death and years of education was used to identify factors from the 7 pathologic measures obtained in the study. Preliminary analyses showed that none of the correlations between measures exceeded 0.5, permitting the inclusion of ordinal and dichotomous variables. 22 Logistic regression was used to examine the associations between the presence of 1 or more APOE-e4 alleles and dementia, controlling for age at death and years of education. The effect of indices representing the severity of Alzheimer pathology and vascular pathology was then investigated by adding these indices to the models with APOE-e4, age at death, and education, and comparing the strength of associations between APOE-e4 and dementia when these indexes were present and absent. Additional models were run in which individual pathologic measures were added to APOE-e4, age at death and education. Finally, associations of the 7 pathologic measures with each other were assessed by w 2 , rank biserial correlation (r rb ), or Spearman correlation (r s ), depending on the types of variables. Table 1 compares characteristics of the 200 participants without an e4 allele and the 67 participants with 1 or more e4 alleles. Those with 1 or more e4 alleles had higher mean counts of neocortical NFT, higher mean counts of neocortical NPs, and higher ratings of the severity of amyloid angiopathy. In addition, they were more likely to be demented at death, and to fulfill study neuropathologic criteria for AD. Other measures, including the 4 nonamyloid vascular measures, were not significantly different.
RESULTS
Principal components analysis of the 7 pathologic measures revealed 3 factors with eigenvalues greater than 1. The first factor had loadings of 0.62 (mean number of neocortical NFT), 0.59 (mean number of neocortical NP), 0.51 (rating of amyloid angiopathy severity), 0.07 (lacunar infarcts), 0.07 (large infarcts), À 0.01 (presence of microinfarcts), and À 0.06 (rating of severity of atherosclerosis in the circle of Willis). The second factor had loadings of 0.61 (large infarcts), 0.55 (lacunar infarcts), 0.45 (rating of severity of atherosclerosis in the circle of Willis), 0.33 (presence of microinfarcts), 0.09 (rating of amyloid angiopathy severity), À 0.06 (mean number of neocortical NFT), and À 0.10 (mean number of neocortical NP). The third factor had only 1 variable loading greater than 0.40:0.76 (presence of microinfarcts). Two indices were created by summing standardized values of neocortical NFT, neocortical NP, and amyloid angiopathy to yield an AD pathology index; and by summing standardized values of atherosclerosis and large and lacunar infarcts to yield a vascular pathology index. Because the third factor consisted of a single variable, the presence of microinfarcts was added independently to the models. Table 2 summarizes multiple logistic regression models with dementia as the outcome. APOE-e4 was strongly associated with dementia [odds ratio (OR) = 2.98; 95% confidence interval (CI), 1.62-5.48)] adjusted for age at death and years of education (Model 1). When the AD pathology index was added to the model, the association of APOE-e4 with dementia was reduced and lost its statistical significance (OR = 1.38; 95% CI, 0.68-2.80) (Model 2). By contrast when the vascular pathology index was added, the association of e4 with dementia changed only slightly (Model 3). The addition of microinfarcts (Model 4) led to a small increase in the OR for APOE-e4. Finally, in the full model (Model 5), both the AD and vascular pathology indices were independently associated with dementia.
To assess the role of individual pathologies, a series of logistic regression analyses were performed in which the APOE-e4 association with dementia was evaluated with addition of each pathologic measure alone ( Table 3) . Addition of the mean count of neocortical NFT eliminated the significant association of APOE-e4 with dementia; none of the other 6 measures eliminated this significant association. However, inclusion of the mean count of neocortical NPs reduced the magnitude of the APOE-e4 OR from 2.98 to 2.22. Significant associations were found between the presence of large and lacunar infarcts (w 2 = 29.3, P<0.0001), large infarcts and ratings of atherosclerosis in the circle of Willis (r rb = 0.30, P<0.01), and lacunar infarcts and atherosclerosis in the circle of Willis (r rb = 0.21, P<0.05). However, there were no significant associations between ratings of amyloid angiopathy and the occurrence of large (r rb = 0.13, NS) or lacunar (r rb = 0.09, NS) infarcts, between ratings of amyloid angiopathy and atherosclerosis (r s = À 0.06, NS), between ratings of amyloid angiopathy and microinfarcts (r s = 0.14, NS), between microinfarcts and either lacunar (w 2 = 1.16, NS) or large (w 2 = 2.41, NS) infarcts, or between microinfarcts and atherosclerosis (r rb = 0.13, NS). The rating of amyloid angiopathy was significantly correlated with both the mean NFT count in the neocortex (r s = 0.36, P<0.0001) and the mean NP neocortical count (r s = 0.33, P<0.0001).
DISCUSSION
Consistent with the previous research, 3 presence of 1 or more APOE-e4 alleles was a strong predictor of dementia. The addition of the index of severity of Alzheimer pathology to the model reduced the strength of this association from 2.98 to 1.38, suggesting that the effect of APOE-e4 on dementia is largely accounted for by more severe AD neuropathology. Addition of an index of cerebrovascular disease, including the degree of atherosclerosis in the circle of Willis and the presence of large and lacunar infarcts, as well as addition of chronic microinfarcts, had little effect on the association between the e4 allele and dementia.
Among the 3 AD-related pathologies, only the mean count of neocortical NFTs when added to a model predicting dementia from APOE-e4, age at death, and education substantially reduced the association between e4 and dementia. This finding suggests that APOE-e4 influences the occurrence of dementia primarily through its association with more severe NFT expression, and is consistent with the results of many clinicopathologic studies including the Nun Study, 23 which found a stronger association of dementia with the frequency of NFTs than with the frequency of NPs.
Our findings for AD neuropathology are in general agreement with those of the ROS, 9 which used a similar approach to analyze data. In that study, the likelihood of clinical AD was strongly associated with the e4 allele in logistic regression models and the association was reduced approximately 50% by addition of a summary measure of global AD pathology reflecting diffuse plaque, NP and NFT densities. However, in contrast to the findings of that study, we did not see a large reduction in the association of e4 with dementia by addition of a measure of mean neocortical NP count. Although the measures of NP density were similar between the 2 studies, there was a large difference in age at death. Participants in the present study were on average more than 5 years older at the time of their death than those in the ROS. Whereas the ROS investigators reported similar associations with dementia of normalized measures of NFTs (OR = 3.59; 95 CI, 1.69-7.60) and NPs (OR = 3.90; 95% CI, 1.99-7.61); normalized measures of NFTs and NPs in the present study demonstrated much stronger associations of NFTs with dementia (OR = 5.17; 95% CI, 2.76-9.71) as compared with NPs (OR = 1.89; 95% CI, 1.42-2.50). It is possible that the difference in findings may be accounted for by increased progression of the AD pathologic process, 24 with NFTs playing a more important role in those who survived to older ages.
A recent publication based on data from the ROS 25 examined the extent to which a dichotomous variable (presence or absence of chronic cerebral infarction) mediated the effect of APOE-e4 on continuous measures of cognitive function. In agreement with the results of the present study, the authors did not find a significant mediation effect of chronic infarction on the association between APOE-e4 and global cognition.
Autopsy-based studies have shown significant correlations between the e4 allele and the density of NPs, [26] [27] [28] NFT, 27, [29] [30] [31] and amyloid deposition. [29] [30] [31] [32] [33] [34] However, some studies have not found an association with amyloid plaques [35] [36] [37] or NFT. 26, 32, 35, 37, 38 With few exceptions, those studies not finding an association were restricted to individuals with clinically diagnosed dementia, whereas those showing an association included substantial numbers of nondemented elderly. The lack of an association seen in some studies may represent a ceiling effect achieved with increasing disease severity. 39 The Catholic sisters that are the focus of this report cover a wide spectrum of both cognitive performance and neuropathology, which may have facilitated finding stronger associations between e4 and AD pathology.
Studies of clinically diagnosed vascular dementia patients have been equivocal with regard to associations with APOE-e4. Some have shown elevated e4 frequencies, [10] [11] [12] [13] whereas others demonstrated normal frequencies of this allele. [40] [41] [42] [43] [44] Similarly, in clinical studies the association of the e4 allele and stroke has been mixed, with some studies reporting a positive association between APOE-e4 and stroke, [45] [46] [47] whereas others have failed to confirm this association. [48] [49] [50] [51] [52] [53] Studies in which strokes were identified by autopsy are relatively few. Two studies 54, 55 found that the frequency of cerebrovascular lesions was not increased in APOE-e4, whereas another group 14 reported that APOE-e4 significantly increased the odds of both cortical and subcortical infarctions. In the present study, we did not find a statistically significant association of APOE-e4 with the presence of large infarcts or lacunar infarcts, the degree of atherosclerosis in the circle of Willis or the presence of chronic microinfarcts. However, the degree of atherosclerosis in the circle of Willis was significantly associated with the presence of both large and lacunar infarcts, and both types of infarcts contributed to the expression of dementia as we have shown previously for the same cohort. 16 The association between cardiovascular disease, atherosclerosis and AD has been controversial. [56] [57] [58] [59] Our results suggest that cerebrovascular and AD lesions do not share APOE-e4 as a common risk factor. Rather they support the hypothesis that vascular lesions increase the clinical expression of an AD process that is accelerated by possession of one or more e4 alleles. An important exception is amyloid angiopathy, which was strongly related to AD neuropathology, but had no association with the severity of atherosclerosis or the occurrence of infarcts.
In summary, the present results suggest the effect of e4 on dementia is mediated almost entirely by the severity of AD pathology. Although infarcts contribute significantly to the occurrence of dementia, this contribution seems unrelated to APOE genotype.
This study has several strengths. These include the ability to compare dementia status before death to detailed measures of AD and vascular pathology at autopsy in a large population genotyped for APOE. Little attrition occurred during the study and the autopsy rate was high, limiting these sources of bias. Because approximately half of the sisters died without becoming demented and a wide spectrum of both AD and vascular pathology was present at autopsy, there was significant power to assess associations between the presence of e4 alleles, dementia, and vascular and AD lesions. Blinding of the neuropathologist to all clinical data eliminated bias due to expectations based on premorbid status.
Limitations include the restriction of AD neuropathologic measures to mean counts of neocortical NFTs and NPs and ratings of severity of amyloid angiopathy. Because we did not know the pathologic burden from sisters when they were alive, the sequence of events from APOE genotype to clinical presentation must be inferred from cross-sectional regression analyses. Finally, the study was conducted entirely on women with a high degree of education and lifestyles that limited exposureto tobacco and alcohol as well as other confounders. Because higher education reduces expression of dementia, 60 a less welleducated sample might be more likely to become demented with less severe neuropathology, resulting in somewhat different associations between APOE-e4, AD neuropathology, and dementia. Our findings, although largely consistent with those of another study of well-educated Catholic nuns, priests, and brothers, 9 need to be replicated in a sample of lay persons with a greater range of educational attainment.
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